For Companies
IDNA_for_companies

Innovation is in our (i)DNA

At iDNA, our motivation is to bring science to practice. Our extensive knowledge means that we can assist with the (co-)development of innovative solutions in software, hardware, and technologies:

Bringing science to practice

At iDNA, our motivation is to bring science to practice. Our partners (including leading universities, companies and hospitals) are at the forefront of innovation in the fields of medical device development, lung cancer treatment, drug development, AI imaging algorithm validation, and other screening-related activities.

Accelerating innovation and R&D (CRO)

In the disease areas mentioned above, iDNA can set up projects and clinical trials (Contract Research Organization) in the following areas:

  • Validation of medical devices
  • Validation of AI medical imaging algorithms in high quality data sets
  • Assistance with biomarker discovery and drug development

The Big-3 diseases

Lung cancer, coronary heart disease (CHD), and chronic obstructive pulmonary disease (COPD) are together known as the ‘Big 3’ diseases, and these diseases and their co-morbidities are also subjects of interest. iDNA can assist in setting up projects and clinical trials related to lung cancer, coronary heart disease, and COPD.

GDPR compliant high quality data sets

All of our collaborations and data sets (imaging and biomaterials) are fully GDPR compliant and participants of our studies are fully consented with their participation. We do our utmost to guarantee the safe handling of privacy sensitive data.

Contact us and we will be glad to discuss collaboration opportunities: